Extended-release methylphenidate – A review of the pharmacokinetic profiles of available preparations

This review provides a brief background to current NICE recommendations for the use of methylphenidate for the treatment of ADHD and summarises pertinent points with respect to the pharmacokinetic differences of the various methylphenidate modified-release products available. In particular this review covers the pharmacokinetic profiles of Delmosart XL, Matoride XL, Xaggitin XL and Xenidate XL; a detailed review of the Medikinet XL, Equasym XL, and Concerta XL products is already available.

Mental HealthMental health and illnessMethylphenidateNewsPaediatric and neonatal medicine

Attachments